{
  "title": "All Eyes on Gilead",
  "itunes:title": "All Eyes on Gilead",
  "description": "<p>Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. This is how Gilead Sciences prepared for the moment.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "7851e6ba-9707-11ea-857e-8fd628a99623",
  "omny:clipId": "ced0cc6a-96bd-4967-b2cd-ae2b007313f8",
  "pubDate": "Fri, 15 May 2020 23:56:46 +0000",
  "itunes:duration": 1105,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/all-eyes-on-gilead"
}